Collectively, these results indicated that DUSP28 is a key molecule responsible for the chemo-resistance and migratory activity, through the ERK1/2 signaling pathway, and targeting DUSP28 with conventional chemotherapy might be an effective strategy for treatment of pancreatic cancers (Fig. 6e). This evidence concerns the gene MAPK3 and pancreatic neoplasm.